Wave Life Sciences Ltd. (WVE) poses a Brand-New Opportunity for Investors with beta value of -1.08

Wave Life Sciences Ltd. (NASDAQ: WVE) open the trading on Wednesday, with a bit cautious approach as it glided -4.96% to $5.94, before settling in for the price of $6.25 at the close. Taking a more long-term approach, WVE posted a 52-week range of $3.15-$7.67.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The Healthcare sector firm’s twelve-monthly sales growth has been 610.91% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 36.03%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -87.04%. This publicly-traded company’s shares outstanding now amounts to $119.16 million, simultaneously with a float of $95.63 million. The organization now has a market capitalization sitting at $726.34 million. At the time of writing, stock’s 50-day Moving Average stood at $5.07, while the 200-day Moving Average is $4.93.

Wave Life Sciences Ltd. (WVE) Ownership Facts and Figures

Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Wave Life Sciences Ltd.’s current insider ownership accounts for 21.80%, in contrast to 74.64% institutional ownership. According to the most recent insider trade that took place on Dec 11 ’23, this organization’s Director bought 1,000,000 shares at the rate of 5.00, making the entire transaction reach 5,000,000 in total value, affecting insider ownership by 19,202,009. Preceding that transaction, on Dec 07 ’23, Company’s 10% Owner bought 3,300,000 for 5.00, making the whole transaction’s value amount to 16,500,000. This particular insider is now the holder of 13,983,761 in total.

Wave Life Sciences Ltd. (WVE) Earnings and Revenue Records

So, what does the last quarter earnings report of the company that was made public on 12/30/2023 suggests? It has posted -$0.15 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$0.23) by $0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.

Wave Life Sciences Ltd.’s EPS decrease for this current 12-month fiscal period is -87.04% and is forecasted to reach -1.07 in the upcoming year.

Wave Life Sciences Ltd. (NASDAQ: WVE) Trading Performance Indicators

Let’s observe the current performance indicators for Wave Life Sciences Ltd. (WVE). It’s Quick Ratio in the last reported quarter now stands at 1.26. The Stock has managed to achieve an average true range (ATR) of 0.42. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.41.

In the same vein, WVE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.55, a figure that is expected to reach -0.19 in the next quarter, and analysts are predicting that it will be -1.07 at the market close of one year from today.

Technical Analysis of Wave Life Sciences Ltd. (WVE)

[Wave Life Sciences Ltd., WVE] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 78.40% While, its Average True Range was 0.41.

Raw Stochastic average of Wave Life Sciences Ltd. (WVE) in the period of the previous 100 days is set at 58.51%, which indicates a major rise in contrast to 29.60% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 79.97% that was lower than 100.56% volatility it exhibited in the past 100-days period.